The National Drug Authority Strategic Plan 2020/2021-2024/2025 builds on the gains achieved in the previous period and also focuses on consolidating efficiency and effectiveness in drug regulation, as provided for within the mandate of the Drug Authority. This strategic plan has been aligned to the...
National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in par...
Problems related to the safety and quality of drugs exist in many places around the world today, in developing and developed countries alike. Some incidents have ended in tragedy, often with children as the victims. They are caused by the use of drugs containing toxic substances or impurities, drugs...
The World Health Organization (WHO), the United Nations Children��s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficie...
The WHA 54.11 WHO medicines strategy acknowledged the four main objectives of WHO��s medicines strategy, namely, to frame and implement policy; to ensure access; to ensure quality, safety and efficacy; and to promote rational use of medicines. The WHO medicines strategy 2004-2007 presents the strate...
The thirty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 16 to 20 November 2015. Mr Cornelis de Joncheere, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. He welcomed all participants on beh...
The schedue provides for control of 98 psychotropical substances which are assigned to one of the four schedues.
This report provides feedback on the FY2017/18 national quantification, an annual exercise conducted by NMS together with MoH and all government Health Facilities (HFs) and aimed to inform accurate planning for the supply of EMHLS in the public sector.
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director-General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny t...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making. This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate s...
The Fifty-third meeting of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) took place in Geneva, Switzerland, from 22 to 26 October 2018. Participants of the meeting were welcomed by Dr Mariângela Simão, Assistant Director-General, Acces...
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulati...
The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) met in Geneva from 16 to 20 October 2017.Dr Suzanne R. Hill, acting Assistant Director of the Health Systems and Innovation Cluster and Director of the Department of Essential Medicines and...
This manual represents the revised and updated edition of the Essential Medicines and Health Supplies�(EMHS) Management Manual, following its initial publication in 2012. The Department of�Pharmaceuticals and Natural Medicines (DPNM) of the Ministry of Health, in collaboration with�development partn...
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all...
The organizations and agencies of the United Nations system and international and nongovernmental organizations are called upon to respond to an increasing number of largescale emergencies and disasters, many of which pose a serious threat to health. Much of the assistance provided in such situation...
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15-64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment...
The thirty-ninth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 6 to 10 November 2017. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting by welcoming all par...
This manual was developed by the Pharmacy Division, Ministry of Health, in collaboration with the Securing Ugandans�� Right to Essential Medicines (SURE) Program with assistance from health workers representing all levels of care. The purpose of this manual is to provide health workers with a refere...
In June 2010, the Ugandan Ministry of Health (MOH) with support from the United States Agency for International Development (USAID)-funded Securing Ugandans�� Right to Essential Medicines (SURE) Program, collected data for the 2010 Pharmaceutical Sector Report. This report presents the findings of t...
